Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

700 public trials 105 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions: Astrocytoma, Glioblastoma, Glioma, +30 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

University of California at Los Angeles Los Angeles, California, United States

Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States

Local Institution - 2105 Orlando, Florida, United States

View all 68 locations

View Trial Details

Recruiting

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

NCT04930653

Conditions: Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

City of Hope Medical Center Duarte, California, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

View Trial Details

Recruiting

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

NCT04904146

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: Lund University Hospital Lund, Sweden

View Trial Details

Recruiting

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

NCT07055477

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

NCT07192471

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: University of California, Irvine Medical Center - Hematology/Oncology Orange, California, United States

Stanford University School of Medicine Stanford, California, United States

Beth Israel Deaconess Medical Center - Research Boston, Massachusetts, United States

Washington University School of Medicine - Oncology Hospital - Public St Louis, Missouri, United States

View all 22 locations

View Trial Details

Recruiting

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

NCT03719105

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations: University of Alabama Birmingham, Alabama, United States

Children's Hospital Orange County Orange, California, United States

University of California San Francisco San Francisco, California, United States

Helen De Vos Grand Rapids, Michigan, United States

View Trial Details

Recruiting

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

NCT01087333

Conditions: Adult T Cell Lymphoma (ATL), Anemia, Anemia, Hemolytic, +39 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

NCT07678229

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Extranodal NK/T-cell Lymphoma, +10 more
Locations: Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases

NCT07727083

Conditions: Aggressive NK-cell Leukemia, DNA Virus Infections, Epstein-Barr Virus Infections, +24 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma

NCT07754890

Conditions: Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions